IRIS
AMATO, FELICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.779
AS - Asia 3.726
NA - Nord America 3.149
SA - Sud America 497
AF - Africa 95
OC - Oceania 16
Totale 11.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.008
SG - Singapore 1.603
IT - Italia 1.558
RU - Federazione Russa 1.197
VN - Vietnam 773
CN - Cina 727
BR - Brasile 416
FR - Francia 263
HK - Hong Kong 246
NL - Olanda 152
DE - Germania 150
GB - Regno Unito 99
FI - Finlandia 91
JP - Giappone 71
CA - Canada 67
IN - India 63
IE - Irlanda 58
BD - Bangladesh 46
MX - Messico 46
AR - Argentina 36
IQ - Iraq 32
PL - Polonia 31
CI - Costa d'Avorio 30
KR - Corea 29
SE - Svezia 24
AT - Austria 23
ZA - Sudafrica 23
ES - Italia 22
UA - Ucraina 20
HU - Ungheria 18
PH - Filippine 18
LT - Lituania 16
ID - Indonesia 15
AU - Australia 14
EC - Ecuador 13
TR - Turchia 13
CO - Colombia 12
TH - Thailandia 12
PK - Pakistan 11
BE - Belgio 9
MA - Marocco 9
SA - Arabia Saudita 8
VE - Venezuela 8
MT - Malta 7
TW - Taiwan 7
CZ - Repubblica Ceca 6
DK - Danimarca 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
DZ - Algeria 5
TN - Tunisia 5
AZ - Azerbaigian 4
EG - Egitto 4
HN - Honduras 4
LU - Lussemburgo 4
BY - Bielorussia 3
ET - Etiopia 3
GR - Grecia 3
JM - Giamaica 3
LY - Libia 3
MK - Macedonia 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
PY - Paraguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BS - Bahamas 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
CM - Camerun 1
CV - Capo Verde 1
GE - Georgia 1
GM - Gambi 1
HR - Croazia 1
IS - Islanda 1
KW - Kuwait 1
Totale 11.246
Salva come PNG Salva come JPEG
Città #
Singapore 764
San Jose 426
Ashburn 286
Moscow 283
Chandler 267
Naples 241
Hong Kong 233
Beijing 225
Napoli 210
Ho Chi Minh City 189
Hanoi 155
Santa Clara 125
Amsterdam 124
Hefei 104
Lauterbourg 86
Los Angeles 85
The Dalles 84
Dong Ket 74
Tokyo 66
Millbury 65
Boston 53
Milan 53
New York 53
Rome 50
Des Moines 49
Munich 49
São Paulo 47
Council Bluffs 44
Princeton 44
Nanjing 39
Buffalo 37
Da Nang 36
Redondo Beach 32
Lawrence 30
Houston 27
Orem 27
Chicago 26
Haiphong 25
Brooklyn 24
Dallas 24
Turku 24
Warsaw 24
Seattle 22
Mexico City 21
Montreal 21
Nuremberg 21
Wilmington 21
Denver 20
Ottawa 20
Seoul 20
Tampa 20
Atlanta 19
Frankfurt am Main 19
Stockholm 19
Manchester 18
Phoenix 17
Helsinki 16
Ottaviano 16
Poplar 16
Ercolano 15
Can Tho 14
Lappeenranta 14
Baghdad 13
Bologna 13
London 13
Abbiategrasso 12
Hải Dương 12
Johannesburg 12
Boardman 11
Formia 11
Washington 11
Biên Hòa 10
Brasília 10
Budapest 10
Charlotte 10
Nanchang 10
Ninh Bình 10
Redwood City 10
Rio de Janeiro 10
Sydney 10
Chennai 9
Dhaka 9
Hebei 9
Jiaxing 9
San Francisco 9
Vienna 9
Afragola 8
Bari 8
Falkenstein 8
Hangzhou 8
Marsala 8
Mumbai 8
Nocera Inferiore 8
Palermo 8
Pavia 8
Salvador 8
Shenyang 8
Tianjin 8
Toronto 8
Turin 8
Totale 5.642
Salva come PNG Salva come JPEG
Nome #
Analisi qualitativa e quantitativa di splicing alternativi mediante una singola reazione di droplet digital PCR 481
MicroRNA come target terapeutici per il trattamento della fibrosi cistica 248
3D Chitosan-Gallic Acid Complexes: Assessment of the Chemical and Biological Properties 202
CFTR expression during cellular senescence 199
Corrigendum: Gut Microbiota Features in Young Children With Autism Spectrum Disorders 196
Economical, legal and ethical considerations on reevaluation and retesting in molecular diagnostics 193
Clinical implication of cellular senescence on CFTR expression. 186
Enhanced frequency of CFTR gene variants in couples who are candidates for assisted reproductive technology treatment. 183
Olfactory performance in Cystic Fibrosis patients 183
Gut Microbiota Features in Young Children with Autism Spectrum Disorders. [*Coretti L. corresponding author] 177
Comprehensive Molecular Analysis of Disease-Related Genes as First-Tier Test for Early Diagnosis, Classification, and Management of Patients Affected by Nonsyndromic Ichthyosis 166
Qualitative and quantitative evaluation of alternative splicing products using the digital droplet PCR 159
Epigenetica, diagnostica e terapia della fibrosi cistica 158
Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis 158
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 155
Cystic Fibrosis: the sense of smell. 155
An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis 154
Cystic Fibrosis: The Sense of Smell 152
Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles 152
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 152
Tropomyosin-related kinase B receptor polymorphisms and isoforms expression in suicide victims 148
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization 146
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR 144
Letter to the Editor: Is there an Indication for Testing the Methylenetetrahydrofolate reductase A1298C Variant in Routine Clinical Settings? 144
A Novel DHPLC-Based Procedure for the Analysis of COL1A1 and COL1A2 Mutations in Osteogenesis Imperfecta. 143
Comparative Evaluation of Nasal and Small Intestine Expression of ACE2, TMPRSS2 and ACE1 and in Children and in Adults 143
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression 142
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 141
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods 139
Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression 138
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 137
Extensive molecular analysis of patients bearing CFTR-related disorders. 136
CONVERSIONE GENICA FRA I GENI CODIFICANTI IL TRIPSINOGENO PRSS1 E PRSS2: UN EVENTO RICOMBINANTE RARO IN DUE PAZIENTI PEDIATRICI. 136
Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells 133
Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation 132
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 132
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium 131
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 131
Valutazione degli effetti del butirrato sulla fisiologia intestinale mediante real-time PCR. 130
L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 126
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 126
The role of functional studies in the diagnosis and treatment of Cystic Fibrosis: comparing the case of the G970D and G970R mutation. 126
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 124
TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. 122
A novel de novo missense mutation in TP63 underlying germline mosaicism in AEC syndrome: Implications for recurrence risk and prenatal diagnosis. 122
Epigenetic effects of butyrate in children with congenital chloride diarrhea: an in-vivo and in-vitro study. 122
MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis 120
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 120
Two cases of microvillous inclusion disease caused by novel mutations in MYO5B gene 119
Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment 118
Analisi molecolare della nuova variante allelica T4Gnella regione 4G/5G del promotore del gene PAI-1. 118
Target Protector PNA: a new tool in Cystic Fibrosis treatment 118
High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel 116
The implication of MBL deficient haplotypes in acute coronary syndrome. 113
Molecular and functional analysis of the promoter region of CFTR gene in CF and CFTR related disorders patients. 111
An Update on Laboratory Diagnosis of Liver Inherited Diseases 111
Molecular analysis of prothrombotic gene variants in patients with acute ischemic stroke and with transient ischemic attack 111
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality 110
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 110
Twelve Novel Mutations in the SLC26A3 Gene in 17 Sporadic Cases of Congenital Chloride Diarrhea 109
The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy 106
Genetic Diseases That Predispose to Early Liver Cirrhosis 106
GENOTYPE PREDICTS THE RESPONSE TO THERAPY IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA. 105
Prothrombotic gene variants in acute myocardial infarction at a young age (yAMI). Rationale for tailored prevention strategies in specific risk-group subjects for acute coronary disease? 104
BUTYRATE MODULATES EPITHELIAL DRA EXPRESSION IN CHILDREN WITH CONGENITAL CHLORIDE DIARRHEA 100
Identificazionee caratterizzazione di mutazioni in regioni regolatorie del gene malattia della fibrosi cistica 100
The relevance of prothrombotic genetic variants in women who experienced pregnancy loss or embryo implantation failure: A retrospective analysis of 1922 cases 99
Ricerca di fattori trascrizionali allele specifici per due nuove varianti riscontrate nelle CSTs di CFTR. 99
Sars-cov-2: One year in the pandemic. What have we learned, the new vaccine era and the threat of sars-cov-2 variants 97
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 97
Cystic fibrosis, molecular genetics for all life 96
Haemophilia A: the consequences of de novo mutations. Two case reports 96
A novel polymorphism in the PAI-1 gene promoter enhances gene expression. A novel pro-thrombotic risk factor? 95
Lung microbiome in cystic fibrosis 93
Patient-derived cell models for personalized medicine approaches in cystic fibrosis 90
Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2 89
Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis? 86
The friendly use of chloroquine in the COVID-19 disease: A warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene 79
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in three subjects with the cystic fibrosis genotype phe508del/unknown and advanced lung disease 76
Porphyromonas somerae in urinary microbiome and its potential metabolic role in bladder cancer 71
Congenital diarrheal disorders: an updated diagnostic approach 70
Evaluation of butyrate efficacy in treatment of congenital chloride diarrhea: from genotype to clinical response. 68
Molecular and Functional Analysis of the Large 5' Promoter Region of CFTR Gene Revealed Pathogenic Mutations in CF and CFTR-Related Disorders. 67
The Kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control 67
Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea 66
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 63
Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype 60
Effect of CFTR Modulators on Oxidative Stress and Autophagy in Non-CFTR-Expressing Cells 50
Editorial Comment to p.Leu636Pro mutation is associated with cystic fibrosis transmembrane conductance regulator-related disorders (congenital bilateral absence of vas deferens) 47
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 43
Mouse intestine as a useful model for CFTR electrophysiology function analysis 34
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients 31
Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in a Cystic Fibrosis Child With L1077P Mutation 31
null 12
Mechanisms of action of butyrate in congenital chloride diarrhea (CLD) 3
Totale 11.503
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 27 95
2021/2022707 51 27 14 26 7 32 13 37 93 113 127 167
2022/2023782 76 52 31 65 75 74 39 68 105 117 62 18
2023/2024623 29 77 90 43 39 59 36 59 27 32 72 60
2024/20252.844 149 142 20 78 107 178 268 218 145 308 1.008 223
2025/20265.344 559 376 552 637 1.054 250 484 395 568 366 103 0
Totale 11.503